Facilitating Implementation of Research Evidence
| ISRCTN | ISRCTN11598502 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN11598502 |
| Protocol serial number | 223646 |
| Sponsor | University of Warwick (UK) |
| Funder | Seventh Framework Programme |
- Submission date
- 04/02/2010
- Registration date
- 16/03/2010
- Last edited
- 23/04/2019
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Other
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
RCN Research Institute
School of Health and Social Studies
University of Warwick
Coventry
CV4 7AL
United Kingdom
| kate.seers@warwick.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Pragmatic randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Facilitating Implementation of Research Evidence: a pragmatic randomised controlled trial with integral qualitative, quantitative and health economic evaluative components |
| Study acronym | FIRE |
| Study objectives | This study aims to advance understanding about the contribution that facilitation and facilitators can make to translating the findings of research into practice and to study different facilitator models to identify whether it is possible to determine a 'good enough' model of facilitation that can address the complex range of factors that influence the uptake of research evidence within the time and resource constraints of day to day service delivery. The objectives of the study are to: 1. Extend current knowledge of facilitation as a process for translating research evidence into practice 2. Evaluate the feasibility and effectiveness of two different models of facilitation in promoting the uptake of research evidence on continence promotion 3. To advance current knowledge of guideline implementation in healthcare, with a particular focus on understanding the impact of contextual factors on the processes and outcomes of implementation 4. Implement a pro-active dissemination strategy that complements the design of the study and facilitates the diffusion of the study findings to a wide policy and practice community throughout Europe and beyond |
| Ethics approval(s) | 1. UK: South East Wales Research Ethics Committee - Panel D, 21/04/2010, ref: 10/WSE04/20; CSP No.: 33062) 2. Ireland: Local ethics committee, 02/03/2010, ref: ECM 4(u) 3. Netherlands: National ethical clearance not required for this study 4. Sweden: Local ethics committee, 11/01/2010, ref: 2009/180631/2; 2009/2:11 |
| Health condition(s) or problem(s) studied | Long-term nursing care |
| Intervention | Arm 1: guidelines on continence care and an implementation guide (control) Arm 2: guidelines on continence care and an implementation guide and type A facilitation (a 12-month development programme run by external facilitators using technical facilitation) Arm 3: guidelines on continence care and an implementation guide and type B facilitation (a 24-month development programme run by external facilitators using enabling facilitation) |
| Intervention type | Other |
| Primary outcome measure(s) |
The extent to which the guidelines are implemented, using clear criteria linked to the guidelines. Follow up of outcome data is at 6, 12, 18 and 24 months after the interventions starts in all arms. Process data is also collected thoughout the study. |
| Key secondary outcome measure(s) |
Clinical outcomes including: |
| Completion date | 31/12/2012 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Senior |
| Sex | All |
| Target sample size at registration | 1200 |
| Total final enrolment | 2313 |
| Key inclusion criteria | 1. Long-term nursing care settings with at least 60 places 2. Publically funded places 3. Residents who are aged 60 years or older 4. Interested in taking part in the study 5. Residents with documented urinary incontinence 6. Participants within each site will include those who have consented to be involved as: 6.1. Facilitators engaged in intervention delivery 6.2. Staff at all levels working in sites delivering care 6.3. Key stakeholders related to sites (e.g. regional administrators, funding agencies) 6.4. Residents and carers |
| Key exclusion criteria | Patients with moderate or severe dementia |
| Date of first enrolment | 01/03/2010 |
| Date of final enrolment | 31/12/2012 |
Locations
Countries of recruitment
- United Kingdom
- England
- Ireland
- Netherlands
- Sweden
Study participating centre
CV4 7AL
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 16/11/2018 | Yes | No | |
| Results article | realist process evaluation results | 16/11/2018 | 23/04/2019 | Yes | No |
| Protocol article | protocol | 27/03/2012 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
23/04/2019: The following changes have been made:
1. Publication reference added.
2. The total final enrolment has been added from the results publication.
19/11/2018: Publication reference added.
14/11/2018: The following changes were made:
1. The publication and dissemination plan was updated.
2. The intention to publish date was updated.